{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Protein expression", "acute lymphoblastic leukemia", "resveratrol", "prednisolone", "MDR1 gene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31030491", "DateCompleted": {"Year": "2019", "Month": "09", "Day": "06"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "29"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2476-762X", "JournalIssue": {"Volume": "20", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Apr", "Day": "29"}}, "Title": "Asian Pacific journal of cancer prevention : APJCP", "ISOAbbreviation": "Asian Pac J Cancer Prev"}, "ArticleTitle": "Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM).", "Pagination": {"StartPage": "1171", "EndPage": "1176", "MedlinePgn": "1171-1176"}, "Abstract": {"AbstractText": ["Objective: Chemotherapy is the most widely recognized technique to regard leukemia and also different sorts of human tumors. In any case, tranquilize protection has stayed as the primary test against the adequacy of medications. Besides, having different unfriendly impacts, chemotherapy drugs are getting to be traded by characteristic modalities for growth treatment. In such manner, natural segments, for example, resveratrol and prednisolone have been recognized to sharpen the leukemic cells to modified cell demise through an arrangement of complex procedures. In this investigation, we have analyzed effect of 15, 50 and 100\u03bcM of resveratrol and 700\u03bcM of prednisolone on the human multidrug protection quality 1 (MDR1) as a notable marker for cell sedate protection. We assessed the impact of resveratrol and prednisolone on MDR1 protein expression in the CCRF-CEM cell line as an agent for intense lymphoblastic leukemia. The investigation was planned to clear up whether. Materials and methods: CCRF-CEM cells linage get under drug treatment with use of resveratrol and prednisolone. Western blot use at 24 and 48 hours with different doses of resveratrol and prednisolone to analysis of MDR1 expression changes. Results: Effect of 15, 50, and 100 micro molar of resveratrol and 700 micro molars of prednisolone on CCRF-CEM cells led to the MDR1 decrease. Western blot use for evaluation of MDR1 protein expression changes. Conclusion: In the present study, we observed that resveratrol and prednisolone, with a dose-dependent effect, can reduce the expression of the MDR1 protein. This reduction of expression demonstrates that resveratrol and prednisolone can overcome to drug resistance created by MDR1."], "CopyrightInformation": "Creative Commons Attribution License"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Talebi", "ForeName": "Mehdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Bahar Aghdam", "ForeName": "Sina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Sciences, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Azimi", "ForeName": "Ako", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Mohammadi", "ForeName": "Hamed", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Karimi Yonjali", "ForeName": "Somayyeh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}, {"Identifier": [], "Affiliation": "Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Asariha", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical sciences, Yasuj, Iran. Email: milad.zadi88@gmail.com"}], "LastName": "Zadi Heydarabad", "ForeName": "Milad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Thailand", "MedlineTA": "Asian Pac J Cancer Prev", "NlmUniqueID": "101130625", "ISSNLinking": "1513-7368"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ABCB1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "ATP Binding Cassette Transporter, Subfamily B"}, {"RegistryNumber": "9PHQ9Y1OLM", "NameOfSubstance": "Prednisolone"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "ATP Binding Cassette Transporter, Subfamily B"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Prednisolone"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Resveratrol"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}], "CoiStatement": "The authors state that there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aggarwal BB, Bhardwaj A, Aggarwal RS, et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783\u201340.", "ArticleIdList": ["15517885"]}, {"Citation": "Ahani-Nahayati M, Solali S, Asanjan KS, et al. Promoter methylation status of survival-related genes in MOLT-4 cells co-cultured with bone marrow mesenchymal stem cells under hypoxic conditions. Cell J (Yakhteh) 2018;20:188.", "ArticleIdList": ["PMC5893290", "29633596"]}, {"Citation": "Al-Abd A, Mahmoud A, El-Sherbiny G, et al. Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro. Cell Proliferat. 2011;44:591.", "ArticleIdList": ["PMC6496784", "22011009"]}, {"Citation": "Amin ML. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;7:DTI.", "ArticleIdList": ["PMC3762612", "24023511"]}, {"Citation": "Athar M, Back JH, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224:274\u201383.", "ArticleIdList": ["PMC2083123", "17306316"]}, {"Citation": "Azimi A, Hagh M, Yousefi B, et al. The effect of prednisolone on miR 15a and miR16-1 expression levels and apoptosis in acute lymphoblastic leukemia cell line: CCRF-CEM. Drug Res. 2016;66:432\u20135.", "ArticleIdList": ["27281445"]}, {"Citation": "Azimi A, Hagh MF, Talebi M, et al. Time-and concentration-dependent effects of resveratrol on miR 15a and miR16-1 expression and apoptosis in the CCRF-CEM acute lymphoblastic leukemia cell line. Asian Pac J Cancer Prev. 2015;16:6463\u20138.", "ArticleIdList": ["26434860"]}, {"Citation": "Cecchinato V, Chiaramonte R, Nizzardo M, et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol. 2007;74:1568\u201374.", "ArticleIdList": ["17868649"]}, {"Citation": "Chekhun VF, Kulik GI, Yurchenko OV, et al. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 2006;231:87\u201393.", "ArticleIdList": ["16356834"]}, {"Citation": "de Moraes ACR, Maranho CK, Rauber GS, Santos-Silva MC. Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. J Clin Lab Anal. 2013;27:62\u201371.", "ArticleIdList": ["PMC6807608", "23292860"]}, {"Citation": "Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res-Fund Mol M. 2003;523:145\u201350.", "ArticleIdList": ["12628512"]}, {"Citation": "Estrov Z, Shishodia S, Faderl S, et al. Resveratrol blocks interleukin-1\u03b2\u2013induced activation of the nuclear transcription factor NF-\u03baB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. 2003;102:987\u201395.", "ArticleIdList": ["12689943"]}, {"Citation": "Gao F, Dong W, Yang W, et al. Expression of Pgp in acute myeloid leukemia and the reversal function of As2O3 on drug resistance. Oncol Lett. 2015;9:177\u201382.", "ArticleIdList": ["PMC4247107", "25435954"]}, {"Citation": "Gautam S, Xu Y, Dumaguin M, Janakiraman N, Chapman R. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 2000;25:639.", "ArticleIdList": ["10734298"]}, {"Citation": "Ghasemi A, Khanzadeh T, Zadi Heydarabad M, et al. Evaluation of BAX and BCL-2 gene expression and apoptosis induction in acute lymphoblastic leukemia cell line CCRFCEM after high-dose prednisolone treatment. Asian Pac J Cancer Prev. 2018;19:2319\u201323.", "ArticleIdList": ["PMC6171400", "30141309"]}, {"Citation": "Gogada R, Prabhu V, Amadori M, Scott R, Hashmi S, Chandra D. Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem. 2011;286:28749\u201360.", "ArticleIdList": ["PMC3190683", "21712378"]}, {"Citation": "Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB. Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci. 2011;1215:150\u201360.", "ArticleIdList": ["PMC3060406", "21261654"]}, {"Citation": "Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001;22:1111\u20137.", "ArticleIdList": ["11470738"]}, {"Citation": "Hano M, Tom\u00e1\u0161ov\u00e1 L, \u0160ere\u0161 M, et al. Interplay between p-Glycoprotein expression and resistance to endoplasmic reticulum stressors. Molecules. 2018;23:337.", "ArticleIdList": ["PMC6017601", "29415493"]}, {"Citation": "Hao X-Y, Bergh J, Brodin O, Heltman U, Mannervik B. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis. 1994;15:1167\u201373.", "ArticleIdList": ["8020151"]}, {"Citation": "Heydarabad MZ, Vatanmakanian M, Nikasa M, HAGH MF. Epigenetic regulation of specific transcription factors in osteogenic differentiation of mesenchymal stem cells. Turk J Biol. 2016;40:1040\u20139."}, {"Citation": "Huang F, Wu X-N, Chen J, Wang W-X, Lu ZF. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Expl Exploratory Ext. 2014;7:1611\u20136.", "ArticleIdList": ["PMC4043584", "24926353"]}, {"Citation": "Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. Blood. 2004;104:1940\u201351.", "ArticleIdList": ["15217827"]}, {"Citation": "Pouyafar A, Heydarabad MZ, Mahboob S, Mokhtarzadeh A, Rahbarghazi R. Angiogenic potential of YKL-40 in the dynamics of tumor niche. Biomed Pharmacother. 2018;100:478\u201385.", "ArticleIdList": ["29477911"]}, {"Citation": "Quan F, Pan C, Ma Q, Zhang S, Yan L. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. Biomed Pharmacother. 2008;62:622\u20139.", "ArticleIdList": ["18804944"]}, {"Citation": "Rauf A, Imran M, Butt MS, et al. Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr. 2018;58:1428\u201347.", "ArticleIdList": ["28001084"]}, {"Citation": "Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol. 2002;83:37\u201348.", "ArticleIdList": ["12650700"]}, {"Citation": "Scheffer GL, Wijngaard PL, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995;1:578\u201382.", "ArticleIdList": ["7585126"]}, {"Citation": "Seve M, Chimienti F, Devergnas S, et al. Resveratrol enhances UVA-induced DNA damage in HaCaT human keratinocytes. Med Chem. 2005;1:629\u201333.", "ArticleIdList": ["16787346"]}, {"Citation": "Stanulla M, Schrappe M. Seminars in hematology. Elsevier; 2009. Treatment of childhood acute lymphoblastic leukemia; pp. 52\u201363.", "ArticleIdList": ["19100368"]}, {"Citation": "Zadi Heydarabad M, Baharaghdam S, Azimi A, et al. The role of tumor suppressor of resveratrol and prednisolone by downregulation of YKL-40 expression in CCRF-CEM cell line. J Cell Biochem. 2019;120:3773\u20139.", "ArticleIdList": ["30426549"]}, {"Citation": "Zadi Heydarabad M, Nikasa M, Vatanmakanian M, Azimi A, Farshdousti Hagh M. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective. J Cell Biochem. 2018;119:4890\u20136.", "ArticleIdList": ["29377275"]}, {"Citation": "Zadi Heydarabad M, Vatanmakanian M, Abdolalizadeh J, et al. Apoptotic effect of resveratrol on human T-ALL cell line CCRF-CEM is unlikely exerted through alteration of BAX and BCL2 promoter methylation. J Cell Biochem. 2018;119:10033\u201340.", "ArticleIdList": ["30132966"]}, {"Citation": "Zadi Heydarabad M, Vatanmakanian M, Abdolalizadeh J, et al. Apoptotic effect of resveratrol on human T-ALL cell line CCRF-CEM is unlikely exerted through alteration of BAX and BCL2 promoter methylation. J Cell Biochem. 2018;119:10033\u201340.", "ArticleIdList": ["30132966"]}, {"Citation": "Zaman G, Flens M, Van Leusden M, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1994;91:8822\u20136.", "ArticleIdList": ["PMC44698", "7916458"]}, {"Citation": "Zhang R, Lu M, Zhang Z, et al. Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-\u03baB and p38 MAPK signaling pathways. Oncol Lett. 2016;12:4147\u201354.", "ArticleIdList": ["PMC5104249", "27895784"]}, {"Citation": "Zhang W, Murao K, Zhang X, et al. Resveratrol represses YKL-40 expression in human glioma U87 cells. BMC Cancer. 2010;10:593.", "ArticleIdList": ["PMC2988030", "21029458"]}]}], "History": [{"Year": "2019", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31030491", "PMC6948888", "10.31557/APJCP.2019.20.4.1171"]}}]}